SMITH SEAN MICHAEL (Principal Accounting Officer) sold 19.6% of their position (1.66K shares) of NEUROGENE INC. on the open market
Open‑market sale worth $1.6K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/12/2022ACC: 0001209191-22-045667
Officer· Principal Accounting Officer
Since Mar 2022
-1.66K
Net shares
Net seller
$1.6K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
5K acquired · 6.66K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+5K
Price / share
—
Trade value
—
% of position
145.7%
8/10/2022
3.43K→8.43K
Common Stock
Direct
Shares
−1.66K
Price / share
$0.99
Trade value
$1.64K
% of position
19.6%
8/10/2022
8.43K→6.78K
Total
Net shares
+3.35K
Net value
-$1.64K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/10/2022 | M · Option Exercise | +5K | — | — | 145.7% | 3.43K | 8.43K |
| Common Stock Direct | 8/10/2022 | S · Sale | −1.66K | $0.99 | $1.64K | 19.6% | 8.43K | 6.78K |
| Total | +3.35K | -$1.64K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
5K shares
Shares
−5K
Strike price
0.00
Held after
5K
Exercisable
—
8/10/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock5K shares | 8/10/2022 | M · Option Exercise | −5K | 0.00 | — | 5K |